Godshalk Welsh Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-22,059
Closed -$744K 121
2022
Q2
$744K Sell
22,059
-1,050
-5% -$36.8K 0.53% 66
2022
Q1
$807K Buy
23,109
+160
+0.7% +$5.47K 0.5% 67
2021
Q4
$699K Buy
22,949
+2,496
+12% +$81.3K 0.4% 73
2021
Q3
$671K Buy
20,453
+8,879
+77% +$284K 0.42% 70
2021
Q2
$358K Buy
+11,574
New +$381K 0.22% 97

Other funds holding OGN

Godshalk Welsh Capital Management's OGN Position: Q3 2022 in Review

Godshalk Welsh Capital Management sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 22,059 shares — an estimated $744K sold.

Godshalk Welsh Capital Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $807K in Q1 2022. 792 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Godshalk Welsh Capital Management reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Godshalk Welsh Capital Management sold 22,059 Organon & Co shares in Q3 2022, an estimated $744K.
  • Godshalk Welsh Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Godshalk Welsh Capital Management's Organon & Co position peaked at $807K in Q1 2022.
  • 792 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Godshalk Welsh Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.